I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 47% ± 19% | |
| epithelial cell | 10 studies | 33% ± 16% | |
| basal cell | 6 studies | 27% ± 13% | |
| endothelial cell | 6 studies | 22% ± 6% | |
| plasmacytoid dendritic cell | 6 studies | 24% ± 6% | |
| fibroblast | 5 studies | 22% ± 5% | |
| epithelial cell of proximal tubule | 4 studies | 20% ± 3% | |
| myofibroblast cell | 4 studies | 16% ± 1% | |
| enterocyte | 4 studies | 21% ± 2% | |
| natural killer cell | 4 studies | 18% ± 1% | |
| deuterosomal cell | 3 studies | 29% ± 5% | |
| hematopoietic precursor cell | 3 studies | 19% ± 4% | |
| pericyte | 3 studies | 18% ± 3% | |
| smooth muscle cell | 3 studies | 17% ± 1% | |
| plasma cell | 3 studies | 29% ± 10% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 2% | |
| type I pneumocyte | 3 studies | 22% ± 6% | |
| abnormal cell | 3 studies | 25% ± 4% | |
| astrocyte | 3 studies | 25% ± 6% | |
| oligodendrocyte precursor cell | 3 studies | 20% ± 2% | |
| dendritic cell | 3 studies | 26% ± 4% | |
| goblet cell | 3 studies | 24% ± 7% | |
| oligodendrocyte | 3 studies | 18% ± 2% | |
| neuron | 3 studies | 28% ± 10% |
